Depression in multiple sclerosis: a review

Siegert, R J·2005·Journal of Neurology, Neurosurgery & Psychiatry

Cited by (723)

Items 201–300 of 723

  1. Cognitive rehabilitation, self-management, psychotherapeutic and caregiver support interventions in progressive neurodegenerative conditions: A scoping review
    Clare, Linda, Teale, Julia C., Toms, Gill, Kudlicka, Aleksandra, Evans, Isobel, Abrahams, Sharon, Goldstein, Laura H., Hindle, John V., Ho, Aileen K., Jahanshahi, Marjan et al. · 2019 · NeuroRehabilitation
  2. Enzyme replacement therapy and fatigue in adults with Pompe disease
    Deniz Güngör, Juna M. de Vries, Esther Brusse, Michelle Elisabeth Kruijshaar, Wim C.J. Hop, Magda Murawska, Linda E.M. van den Berg, Arnold J.J. Reuser, Pieter A. van Doorn, Marloes L. C. Hagemans et al. · 2013 · Molecular Genetics and Metabolism
  3. Muscular, cardiac, ventilatory and metabolic dysfunction in patients with multiple sclerosis: Implications for screening, clinical care and endurance and resistance exercise therapy, a scoping review
    Inez Wens, Bert O. Eijnde, Dominique Hansen · 2016 · Journal of the Neurological Sciences
  4. Increased incidence of rheumatoid arthritis in multiple sclerosis
    Chia‐Chun Tseng, Shun‐Jen Chang, Wen‐Chan Tsai, Tsan‐Teng Ou, Cheng‐Chin Wu, Wan‐Yu Sung, Ming‐Chia Hsieh, Jeng‐Hsien Yen · 2016 · Medicine
  5. Depression is a predictor for balance in people with multiple sclerosis
    Alia A. Alghwiri, Hanan W. Khalil, Alham Al‐Sharman, Khalid El‐Salem · 2018 · Multiple Sclerosis and Related Disorders
  6. An integrative cognitive rehabilitation using neurologic music therapy in multiple sclerosis
    Federica Impellizzeri, Simona Leonardi, Dèsiréè Latella, Maria Grazia Maggio, Marilena Foti Cuzzola, Margherita Russo, Edoardo Sessa, Placido Bramanti, Rosaria De Luca, Rocco Salvatore Calabrò · 2020 · Medicine
  7. A Quantitative Synthesis of Eight Decades of Global Multiple Sclerosis Research Using Bibliometrics
    Ismail Ibrahim Ismail, Mohammed Saqr · 2022 · Frontiers in Neurology
  8. Depression — a common disorder across a broad spectrum of neurological conditions: a cross-sectional nationally representative survey
    Andrew G. M. Bulloch, Kirsten Marie Fiest, Jeanne V.A. Williams, Dina H. Lavorato, Sandra A. Berzins, Nathalie Jetté, Tamara Milka Pringsheim, Scott Burton Patten · 2015 · General Hospital Psychiatry
  9. Neuromyelitis optica, psychiatric symptoms and primary polydipsia: a case report
    Josh D. Woolley, Vanja C. Douglas, Bruce Cree · 2010 · General Hospital Psychiatry
  10. Advanced Symptom Management in Multiple Sclerosis
    Elizabeth Crabtree‐Hartman · 2017 · Neurologic Clinics
  11. Relationship between social cognition and fatigue, depressive symptoms, and anxiety in multiple sclerosis
    Helen M. Genova, Katie Lancaster, Jean Lengenfelder, Christopher P. Bober, John DeLuca, Nancy D. Chiaravalloti · 2019 · Journal of Neuropsychology
  12. Expanding Poststroke Depression Research: Movement Toward a Dyadic Perspective
    Michael J. McCarthy, Karen S. Lyons, Laurie E. Powers · 2011 · Topics in Stroke Rehabilitation
  13. Sub-typing CFS patients on the basis of ‘minor’ symptoms
    Malvin N. Janal, Donald S. Ciccone, Benjamin H. Natelson · 2006 · Biological Psychology
  14. Under-treated depression negatively impacts lifestyle behaviors, participation and health-related quality of life among older people with multiple sclerosis
    Michelle Ploughman, Elizabeth M. Wallack, Tanaya Chatterjee, Megan C. Kirkland, Marie E. Curtis · 2020 · Multiple Sclerosis and Related Disorders
  15. Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosis
    Michael M. Ehrensperger, Andrea Grether, Georg Romer, Manfred Berres, Andreas Urs Monsch, Ludwig Kappos, Barbara Steck · 2008 · Multiple Sclerosis Journal
  16. A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis
    H. Hildebrandt, P. Eling · 2014 · Journal of Clinical and Experimental Neuropsychology
  17. SCI and depression: Does inflammation commandeer the brain?
    Kiralyn Brakel, Michelle A. Hook · 2019 · Experimental Neurology
  18. Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer
    Katharina Hüfner, Anne Oberguggenberger, Cláudia Adriana Kohl, Stephanie Beate Geisler, Eva‐Maria Gamper, Verena Meraner, Jonas Egeter, Michael Hubalek, Beate Beer, Dietmar Fuchs et al. · 2015 · Psychoneuroendocrinology
  19. Redefining functionality and treatment efficacy in multiple sclerosis
    Foley, John F., Brandes, David W. · 2009 · Neurology
  20. CD40-TNF activation in mice induces extended sickness behavior syndrome co-incident with but not dependent on activation of the kynurenine pathway
    Flurin Cathomas, René Fuertig, Hannes Sigrist, Gregory N Newman, Vanessa Hoop, Manuela R. Bizzozzero, Andreas Mueller, Andreas H. Luippold, Angelo Ceci, Bastian Hengerer et al. · 2015 · Brain Behavior and Immunity
  21. Multiple sclerosis-related fatigue: the role of impaired corticospinal responses and heightened exercise fatigability
    Kyla D. Coates, Saied Jalal Aboodarda, Renata Lopes Krüger, Tristan Martin, Luanne M. Metz, Scott E. Jarvis, Guillaume Y. Millet · 2020 · Journal of Neurophysiology
  22. Transcranial magnetic stimulation for the treatment of depression in neurologic disorders
    Felipe Fregni, Álvaro Pascual‐Leone · 2005 · Current Psychiatry Reports
  23. Cognitive behaviour therapy for common mental disorders in people with Multiple Sclerosis: A bench marking study
    Askey-Jones, S., David, A.S., Silber, E., Shaw, P., Chalder, T. · 2013 · Behaviour Research and Therapy
  24. The relationship between cognitive fusion, stigma, and well-being in people with multiple sclerosis
    Valvano, Abbey, Floyd, Rebecca M., Penwell-Waines, Lauren, Stepleman, Lara, Lewis, Kimberly, House, Amy · 2016 · Journal of Contextual Behavioral Science
  25. Mindfulness in Motion for People with Multiple Sclerosis: A Feasibility Study.
    Gilbertson, Rachel M., Klatt, Maryanna D. · 2017 · International Journal of MS Care
  26. The progress of cognitive decline in newly diagnosed MS patients
    E. Hankomäki, Juha Multanen, Esko Kinnunen, Päivi I Hämäläinen · 2013 · Acta Neurologica Scandinavica
  27. Physical Health Problems after Disasters
    Joris C. Yzermans, Bellis van den Berg, Anja Dirkzwager · 2009 · Cambridge University Press eBooks
  28. Emotional dysfunctions in neurodegenerative diseases
    Leonie Anne Kathrin Loeffler, Sina Radke, Carmen Morawetz, Birgit Derntl · 2015 · The Journal of Comparative Neurology
  29. Disability Status, Disease Parameters, Defense Styles, and Ego Strength Associated with Psychiatric Complications of Multiple Sclerosis
    T. Hyphantis, Konstantinos Christou, Stavroula Kontoudaki, C. Mantas, G. Papamichael, P. Goulia, S. Konitsiotis, V. Mavreas · 2008 · International Journal of Psychiatry in Medicine
  30. Cognitive Dysfunction in Multiple Sclerosis
    Bonnie I. Glanz, Maria K. Houtchens · 2012 · Wiley eBooks
  31. Depression mediates the relationship between fatigue and mental health-related quality of life in multiple sclerosis
    Fidao, Alexander, De Livera, Alysha, Nag, Nupur, Neate, Sandra, Jelinek, George A, Simpson-Yap, Steve · 2021 · Multiple Sclerosis and Related Disorders
  32. Cognitive impairment in multiple sclerosis: from phenomenology to neurobiological mechanisms
    K. A. Jellinger · 2024 · Journal of Neural Transmission
  33. Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue
    Karthik Nagaraj, Arun B. Taly, Anupama Gupta, Chandrajit Prasad, Rita Christopher · 2013 · Journal of Neurosciences in Rural Practice
  34. Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
    Alessandra Lugaresi, Travaglini, Erika Pietrolongo, Eugenio Pucci, MARCO C. ONOFRJ, Maria di Ioia · 2013 · Neuropsychiatric Disease and Treatment
  35. Comparison of psychiatric disturbances in patients with multiple sclerosis and neuromyelitis optica
    Joon Sung Shin, Young Nam Kwon, Yoobin Choi, Jae Yeon Lee, Yoonji Irene Lee, Ju Hyun Hwang, Soo‐Hee Choi, Sung‐Min Kim · 2019 · Medicine
  36. Major depression favors the expansion of Th17-like cells and decrease the proportion of CD39+Treg cell subsets in response to myelin antigen in multiple sclerosis patients
    Priscila M. Sacramento, Marisa C. Sales, Taissa de Matos Kasahara, Clarice Monteiro, Hugo A. A. Oyamada, Aleida Dias, Lana M. Lopes, Camilla Castro, Átila Duque Rossi, Lucas Matos Millioni et al. · 2022 · Cellular and Molecular Life Sciences
  37. Improving Compliance with Interferon-β Therapy in Patients with Multiple Sclerosis
    Emilio Portaccio, Maria Pia Amato · 2009 · CNS Drugs
  38. The incidence and prevalence of fibromyalgia are higher in multiple sclerosis than the general population: A population-based study
    Ruth Ann Marrie, Bo Nancy Yu, Stella Leung, Lawrence J. Elliott, Sharon Warren, Christina M. Wolfson, Helen L. Tremlett, James Blanchard, John D. Fisk · 2012 · Multiple Sclerosis and Related Disorders
  39. Do Flexible Goal Adjustment and Acceptance Help Preserve Quality of Life in Patients with Multiple Sclerosis?
    Stefaan Van Damme, Annelies De Waegeneer, Jan Debruyne · 2015 · International Journal of Behavioral Medicine
  40. The relationship between fatigability and sleep quality in people with multiple sclerosis
    Mayis Aldughmi, Jessie M. Huisinga, SHARON G. LYNCH, Catherine F Siengsukon · 2016 · Multiple Sclerosis Journal - Experimental Translational and Clinical
  41. A complex relation between depression and multiple sclerosis: a descriptive review
    F. Corallo, Viviana Lo Buono, R. Genovese, Rosanna Palmeri, M. Di Cara, C. Rifici, E. Sessa, G. D'Aleo, F. Galletti, L. Bonanno et al. · 2019 · Neurological Sciences
  42. A genome-wide association study of emotion dysregulation: Evidence for interleukin 2 receptor alpha
    Abigail D. Powers, Lynn M. Almli, Alicia K. Smith, Adriana Lori, Jennifer M. Leveille, Kerry James Ressler, Tanja Jovanović, Bekh Bradley · 2016 · Journal of Psychiatric Research
  43. Our disease: a qualitative meta‐synthesis of the experiences of spousal/partner caregivers of people with multiple sclerosis
    Damien Appleton, Noelle Robertson, Laura Mitchell, Rosie Lesley · 2018 · Scandinavian Journal of Caring Sciences
  44. Evidence-Based Pharmacologic Interventions for Geriatric Depression
    Bindu Shanmugham, Jordan F. Karp, Rebecca A. Drayer, Charles F. Reynolds, George S. Alexopoulos · 2005 · Psychiatric Clinics of North America
  45. Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review
    Agniete Kampaite, Rebecka Gustafsson, Elizabeth N. York, Peter Foley, Niall MacDougall, Mark E. Bastin, Siddharthan Chandran, Adam D. Waldman, Rozanna Meijboom · 2024 · PLoS ONE
  46. MS care: integrating advanced therapies and holistic management
    Gavin Giovannoni, Helen L Ford, Klaus Schmierer, Rod Middleton, Andrea Stennett, Ian M. Pomeroy, Leonora K. Fisniku, Antonio Scalfari, Colin Bannon, Ruth Stross et al. · 2024 · Frontiers in Neurology
  47. The contribution of disease severity, depression and negative affectivity to fatigue in multiple sclerosis: A comparison with ulcerative colitis
    Bol, Yvonne, Duits, Annelien A., Vertommen-Mertens, Christianne E.R., Hupperts, Raymond M.M., Romberg-Camps, Mariëlle J.L., Verhey, Frans R.J., Vlaeyen, Johan W.S. · 2010 · Journal of Psychosomatic Research
  48. Central and peripheral anti-inflammatory effects of maprotiline on carrageenan-induced paw edema in rats
    Valiollah Hajhashemi, Hossein Sadeghi, Mohsen Minaiyan, Ahmad Movahedian, Ardeshir Talebi · 2010 · Inflammation Research
  49. Novel insights into the mechanisms underlying depression-associated experimental autoimmune encephalomyelitis
    Eduardo Pereira Duarte-Silva, Danielle S. Macêdo, Michael H. J. Maes, Christina Alves Peixoto · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  50. Novel Treatment Targets Based on Insights in the Etiology of Depression: Role of IL-6 Trans-Signaling and Stress-Induced Elevation of Glutamate and ATP
    Hans O. Kalkman · 2019 · Pharmaceuticals
  51. Protocol for the saMS trial (supportive adjustment for multiple sclerosis): a randomized controlled trial comparing cognitive behavioral therapy to supportive listening for adjustment to multiple sclerosis
    R. Moss-Morris, L. Dennison, L. Yardley, S. Landau, Suzanne Roche, P. McCrone, T. Chalder · 2009 · BMC Neurology
  52. Chronic Illness and Mental Health
    Tracey A. Revenson, Michael A. Hoyt · 2015 · Elsevier eBooks
  53. The efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trial.
    Carletto, Sara, Borghi, Martina, Francone, Diana, Scavelli, Francesco, Bertino, Gabriella, Cavallo, Marco, Malucchi, Simona, Bertolotto, Antonio, Oliva, Francesco, Ostacoli, Luca · 2016 · BMC Neurology
  54. Quality of life in multiple sclerosis: Effects of current treatment options
    Odysseas Kargiotis, Anna N. Paschali, Lambros Messinis, Panagiotis Papathanasopoulos · 2010 · International Review of Psychiatry
  55. Inflammation increases the development of depression behaviors in male rats after spinal cord injury
    Kiralyn Brakel, Miriam Aceves, Aryana Garza, Chaeyoung Yoo, Gabriel Escobedo, Nishah Panchani, Lee A. Shapiro, Michelle A. Hook · 2021 · Brain Behavior & Immunity - Health
  56. Mitochondrial DNA T4216C and A4917G variations in multiple sclerosis
    Sasan Andalib, Mahnaz Talebi, Ebrahim Sakhinia, Mehdi Farhoudi, Homayoun Sadeghi‐Bazargani, ALBERT H. GJEDDE · 2015 · Journal of the Neurological Sciences
  57. Interferon therapy for ocular disease
    Friederike Mackensen, Regina Max, Matthias Dieter Becker · 2006 · Current Opinion in Ophthalmology
  58. Treatment of Mood Disorders in Multiple Sclerosis
    Luís Pintor, Roberto Sánchez, Eva Baillès Lázaro · 2014 · Current Treatment Options in Neurology
  59. Measuring life quality, physical function and psychological well-being in neurological illness
    L. O'Doherty, A. Hickey, O. Hardiman · 2010 · Amyotrophic Lateral Sclerosis
  60. Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation
    G. J. Meléndez‐Torres, Peter Auguste, Xavier Armoiry, Hendramoorthy Maheswaran, Rachel A. Court, Jason J. Madan, Alan Kan, Stephanie Lin, Carl E Counsell, Jacoby V. Patterson et al. · 2017 · Health Technology Assessment
  61. Unraveling the mystery of white matter in depression: A translational perspective on recent advances
    Mate Abraham, Annakarina Mundorf, Katja Brodmann, Nadja Freund · 2022 · Brain and Behavior
  62. The effect of smoking on the symptoms and progression of multiple sclerosis: a review
    Afsaneh Shirani · 2010 · Journal of Inflammation Research
  63. Neuroprotective Methodologies in the Treatment of Multiple Sclerosis Current Status of Clinical and Pre-clinical Findings
    Tarun Kapoor, Sidharth Mehan · 2020 · Current Drug Discovery Technologies
  64. Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis
    Yára Dadalti Fragoso, Tarso Adoni, Andrea Anacleto, Paulo Diniz da Gama, Marcus Vinicus Magno Goncalves, André Palma da Cunha Matta, Mônica Koncke Fiuza Parolin · 2014 · Practical Neurology
  65. Default network activity is a sensitive and specific biomarker of memory in multiple sclerosis
    James F. Sumowski, Glenn R. Wylie, Victoria M. Leavitt, Nancy D. Chiaravalloti, John DeLuca · 2012 · Multiple Sclerosis Journal
  66. (R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice
    Xingming Wang, Lijia Chang, Yunfei Tan, Youge Qu, Jiajing Shan, Kenji Hashimoto · 2021 · Brain Research Bulletin
  67. Association of personality traits with physical function, cognition, and mood in multiple sclerosis
    Anne Kever, Elizabeth Walker, Claire Riley, Rock A. Heyman, Zongqi Xia, Victoria M. Leavitt · 2022 · Multiple Sclerosis and Related Disorders
  68. A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial
    Cesare Cavalera, Francesco Pagnini, Marco Rovaris, Laura Mendozzi, Luigi Pugnetti, Massimo Garegnani, Enrico Molinari · 2016 · Trials
  69. Epigenetic Drugs for Multiple Sclerosis
    J. Peedicayil · 2016 · Current Neuropharmacology
  70. Personality and Primary Emotional Traits: Disentangling Multiple Sclerosis Related Fatigue and Depression
    Cornelia Sindermann, Jochen Saliger, Jørn Nielsen, H. Karbe, Sebastian A. Markett, Maria Stavrou, Christian Montag · 2017 · Archives of Clinical Neuropsychology
  71. The effects of acute aerobic exercise on mood and inflammation in individuals with multiple sclerosis and incomplete spinal cord injury
    Scott Donia, David J. Allison, Kimberley Lyn Gammage, David S. Ditor · 2019 · Neurorehabilitation
  72. Precision medicine in perinatal depression in light of the human microbiome
    Beatriz Peñalver Bernabé, Pauline M. Maki, Shannon M. Dowty, Mariana Lauren Cralle Salas, Lauren E. Cralle, Zainab Shah, Jack A. Gilbert · 2020 · Psychopharmacology
  73. Coping with Multiple Sclerosis: Considerations and Interventions
    K. McNulty · 2007 · Springer eBooks
  74. The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study
    Alison M. Mackay, Robert Michael Buckingham, Raymond S. Schwartz, Suzanne Jean Hodgkinson, Roy Gary Beran, Dennis John Cordato · 2014 · International Journal of MS Care
  75. Depressive-like-behavior and proinflamatory interleukine levels in the brain of rats submitted to pneumococcal meningitis
    Tatiana Barichello, Ivonete dos Santos, Geovana D. Savi, Lutiana Roque Simões, Jaqueline S. Generoso, Clarissa Martinelli Comim, Daniela Sachs, Antônio Lúcio Teixeira, João Quevedo · 2010 · Brain Research Bulletin
  76. Patients' perspectives on quality of mental health care for people with MS
    David J. Rintell, Debra Frankel, Sarah L. Minden, Bonnie I. Glanz · 2012 · General Hospital Psychiatry
  77. Coping Strategy and Anxiety Evolution in Multiple Sclerosis Patients Initiating Interferon-Beta Treatment
    Thibault Moreau, Nicolas Schmidt, Olivier Joyeux, Catherine Bungener, Véronique Souvignet · 2009 · European Neurology
  78. Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study
    Seyed Mohammad Seyedsaadat, Mozaffar Hosseininezhad, Babak Bakhshayesh, Seyedeh Nastaran Seyed Saadat, Nabizadeh Sp · 2013 · Neurological Sciences
  79. Assessment of sexual function in women with neurological disorders: A review
    Frédérique J. Courtois, Marina Gérard, Kathleen F. Charvier, David B. Vodušek, G. Amarenco · 2017 · Annals of Physical and Rehabilitation Medicine
  80. Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study
    Christos Bakirtzis, Eleni Konstantinopoulou, Dawn Wendy Langdon, Eirini Grigoriadou, F. Minti, Ioannis Nikolaidis, Marina Kleopatra Boziki, Theano Tatsi, Panagiotis Ioannidis, Theodoros Karapanayiotides et al. · 2018 · Journal of the Neurological Sciences
  81. Changes in Activity Participation After Multiple Sclerosis Diagnosis
    Yael Goverover, Helen M. Genova, Angela Davies Smith, Jean Lengenfelder, Nancy D. Chiaravalloti · 2019 · International Journal of MS Care
  82. Quality of life of patients with multiple sclerosis and neuromyelitis optica spectrum disorders: Cross-sectional and longitudinal analysis
    Seungmin Kim, Eun‐Jae Lee, Keon Woo Kim, Dayoung Seo, Seongshin Moon, Kwang‐Kuk Kim, Young‐Min Lim · 2022 · Multiple Sclerosis and Related Disorders
  83. Recognizing and Treating Common Psychiatric Disorders in Multiple Sclerosis
    Jeffrey A. Wilken, Cynthia L. Sullivan · 2007 · The Neurologist
  84. Mood and anxiety disorders in patients with multiple sclerosis
    F. Uğuz, Z. Akpınar, İshak Özkan, S. Tokgoz · 2008 · International journal of psychiatry in clinical practice
  85. Choice of psychological coping in laryngectomized, head and neck squamous cell carcinoma patients versus multiple sclerosis patients
    Anne K. H. Aarstad, Kirsten Lode, J. P. Larsen, Edvin Bru, Hans Jørgen Aarstad · 2010 · European Archives of Oto-Rhino-Laryngology
  86. Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
    Vahid Shaygannejad, Omid Mirmosayyeb, Nasim Nehzat, Mahsa Ghajarzadeh · 2021 · Neurological Sciences
  87. Stress and memory bias interact to predict depression in multiple sclerosis.
    Joe Beeney, Peter A. Arnett · 2008 · Neuropsychology
  88. Tele-exercise in multiple sclerosis: Systematic review and meta-analysis of effects on fatigue, depression, and overall health
    Parisa Najafi, Robert Wayne Motl, Mehrzad Moghadasi · 2024 · Multiple Sclerosis and Related Disorders
  89. Multimodal Treatment of Nasopharyngeal Carcinoma in Children, Adolescents and Young Adults-Extended Follow-Up of the NPC-2003-GPOH Study Cohort and Patients of the Interim Cohort
    Tristan Römer, Sabrina Franzen, Hanna Kravets, Ahmed Farrag, Anna M. Makowska, Hans Christiansen, Michael J. Eble, Beate Timmermann, Gundula Staatz, Felix Manuel Mottaghy et al. · 2022 · Cancers
  90. Graph-Based Analysis of Brain Connectivity in Multiple Sclerosis Using Functional MRI: A Systematic Review
    Sara Hejazi, Waldemar Karwowski, Farzad V. Farahani, Tadeusz Marek, Peter A. Hancock · 2023 · Brain Sciences
  91. Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman
    A. Al-Asmi, S. Al-Rawahi, Zahir Saif Al-Moqbali, Y. Al-Farsi, M. Essa, May El-Bouri, Roopa P. Koshy, A. Gujjar, P. Jacob, Abeer Al-Hodar et al. · 2015 · BMC Neurology
  92. Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial
    Rosa E. Boeschoten, Joost Dekker, Bernard M.J. Uitdehaag, Chris H. Polman, Emma Hubertine Collette, Pim J. Cuijpers, Aartjan T.F. Beekman, Patricia van Oppen · 2012 · BMC Psychiatry
  93. Biological outcome measurements for behavioral interventions in multiple sclerosis
    Anja Fischer, Christoph Heesen, Stefan Michael Gold · 2011 · Therapeutic Advances in Neurological Disorders
  94. Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy Volunteers
    Kerri A. Schoedel, Laura E. Pope, Edward M. Sellers · 2012 · Clinical Drug Investigation
  95. Vortioxetine ameliorates experimental autoimmune encephalomyelitis model of multiple sclerosis in mice via activation of PI3K/Akt/CREB/BDNF cascade and modulation of serotonergic pathway signaling
    Marwa S Shafiek, Radwa Y. Mekky, Noha Nagah Nassar, Mohammed F. El-Yamany, Mostafa Adel Rabie · 2024 · European Journal of Pharmacology
  96. Les troubles de l’humeur et des émotions dans la sclérose en plaques : une revue de la littérature
    S. Montel, C. Bungener · 2007 · Revue Neurologique
  97. Symptom overlap in anxiety and multiple sclerosis
    Seán Ó Donnchadha, Teresa Burke, Jessica Bramham, Marie Claire O’Brien, Robert Whelan, Richard B. Reilly, Hanni S. M. Kiiski, Roisin M Lonergan, Katie Kinsella, Siobhan B Kelly et al. · 2013 · Multiple Sclerosis Journal
  98. Pharmacological management of depression in patients with multiple sclerosis
    Mauro Giovanni Carta, Pasquale Paribello, Annalisa Anastasia, Domenico De Berardis, Antônio Egídio Nardi, Michele Fornaro · 2018 · Expert Opinion on Pharmacotherapy
  99. Predicting Multiple Sclerosis Outcomes During the COVID-19 Stay-at-home Period: Observational Study Using Passively Sensed Behaviors and Digital Phenotyping
    Prerna Chikersal, Shruthi Venkatesh, Karman Masown, Elizabeth Walker, Danyal Ahmed Quraishi, Anind K. Dey, Mayank Goel, Zongqi Xia · 2022 · JMIR Mental Health
  100. Difference in Motor Fatigue between Patients with Stroke and Patients with Multiple Sclerosis: A Pilot Study
    Aida Sehle, Manfred Vieten, Annegret Mündermann, Christian Dettmers · 2014 · Frontiers in Neurology